We are live on ! Find out more
TI

Telemetry Investments Portfolio holdings

AUM $63.3M
1-Year Est. Return 0.06%
This Fund
S&P 500
This Quarter Est. Return
+30.32%
1 Year Est. Return
+0.06%
3 Year Est. Return
+77.42%
5 Year Est. Return
+156.79%
10 Year Est. Return
AUM
$30M
AUM Growth
-$4.67M
Cap. Flow
-$6.12M
Cap. Flow %
-20.38%
Top 10 Hldgs %
58.16%
Holding
63
New
11
Increased
7
Reduced
13
Closed
22

Sector Composition

Rank Sector Weight
1 Healthcare 65.46%
2 Miscellaneous 17.14%
3 Technology 5.05%
4 Communication Services 3.84%
5 Energy 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EE
26
DELISTED
El Paso Electric Company
EE
$311K 1.04%
4,582
-1,418
-24% -$95.5K
NEM icon
27
Newmont
NEM
$135B
$261K 0.87%
6,000
-2,576
-30% -$101K
B
28
Barrick Mining
B
$75.1B
$260K 0.87%
14,000
-2,000
-13% -$34.3K
SYK icon
29
Stryker
SYK
$127B
$252K 0.84%
+1,200
New +$249K
WMGI
30
DELISTED
Wright Medical Group Inc
WMGI
$229K 0.76%
+7,500
New +$196K
MPC icon
31
Marathon Petroleum
MPC
$104B
$228K 0.76%
+3,780
New +$236K
CDOR
32
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$222K 0.74%
20,083
+4,500
+29% +$49.8K
VMRK
33
Vivmark Residential
VMRK
$26.1B
$210K 0.7%
+2,600
New +$221K
TCON
34
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$159K 0.53%
3,395
-194
-5% -$12.7K
ELGX
35
DELISTED
Endologix Inc
ELGX
$129K 0.43%
81,460
BLPH
36
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$118K 0.39%
22,533
ROSE
37
DELISTED
Rosehill Resources Inc. Class A
ROSE
$81K 0.27%
63,137
DPLO
38
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$68K 0.23%
+17,000
New +$79.8K
ROSEW
39
DELISTED
Rosehill Resources Inc.
ROSEW
$6K 0.02%
61,260
ADP icon
40
Automatic Data Processing
ADP
$114B
-1,500
Closed -$242K
BHC icon
41
PUT
Bausch Health
BHC
$2.36B
-65,200
Closed -$1.43M
BN icon
42
Brookfield
BN
$92.3B
-11,676
Closed -$221K
CI icon
43
Cigna
CI
$73.7B
-2,305
Closed -$350K
GS icon
44
Goldman Sachs
GS
$301B
-1,200
Closed -$249K
MSFT icon
45
Microsoft
MSFT
$3.81T
-1,500
Closed -$209K
MTNB icon
46
Matinas BioPharma
MTNB
$2.94M
-8,631
Closed -$272K
ORMP icon
47
Oramed Pharmaceuticals
ORMP
$209M
-10,000
Closed -$32K
SNDX icon
48
Syndax Pharmaceuticals
SNDX
$1.74B
-13,000
Closed -$97K
VSTM icon
49
Verastem
VSTM
$654M
-9,550
Closed -$139K
WFC icon
50
Wells Fargo
WFC
$262B
-6,180
Closed -$312K

Similar funds

Telemetry Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Telemetry Investments held 63 positions worth $30M, down 13% from $34.7M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Telemetry Investments withdrew a net $6.12M in Q4 2019, closing 22 positions and reducing 13 holdings. Its most notable exit was Celgene Corp, an estimated $2.38M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 57% a quarter earlier, followed by Miscellaneous and Technology.

Against the trend, Telemetry Investments opened a new position in iShares MSCI Emerging Markets ETF worth $1.12M.

  • Telemetry Investments's largest Q4 2019 buy was iShares MSCI Emerging Markets ETF: 25,000 shares worth $1.12M.
  • Telemetry Investments added most to Affimed in Q4 2019, an estimated $389K increase.
  • Telemetry Investments's biggest Q4 2019 reduction was Kadmon Holdings, Inc., cutting an estimated $1.58M.
  • Telemetry Investments fully exited Celgene Corp in Q4 2019, selling an estimated $2.38M.
  • Telemetry Investments's ten largest holdings make up 58% of its $30M portfolio in Q4 2019.
  • Telemetry Investments opened 11 new positions and closed 22 in Q4 2019.
  • Telemetry Investments's portfolio value fell 13% quarter-over-quarter to $30M.

Based on Telemetry Investments's 13F filing for Q4 2019, filed 14 Feb 2020.